The Prognostic Role of Procalcitonin in Critically Ill Patients Admitted in a Medical Stepdown Unit: A Retrospective Cohort Study

[1]  Gang Liu,et al.  Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.

[2]  T. Osborn,et al.  Sepsis in the older person: The ravages of time and bacteria , 2018, Emergency medicine Australasia : EMA.

[3]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[4]  Michel Wolff,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.

[5]  T. Walsh,et al.  Early troponin I in critical illness and its association with hospital mortality: a cohort study , 2017, Critical Care.

[6]  Ashitha L. Vijayan,et al.  Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy , 2017, Journal of Intensive Care.

[7]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[8]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[9]  L. Su,et al.  Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis , 2015, PloS one.

[10]  H. Wunsch,et al.  The role of stepdown beds in hospital care. , 2014, American journal of respiratory and critical care medicine.

[11]  Fiona Lecky,et al.  The Glasgow Coma Scale at 40 years: standing the test of time , 2014, The Lancet Neurology.

[12]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[13]  P. Schlattmann,et al.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[14]  J. Dekker,et al.  Promising new assays and technologies for the diagnosis and management of infectious diseases. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Jensen,et al.  Procalcitonin increase in early identification of critically ill patients at high risk of mortality* , 2006, Critical care medicine.

[16]  Stephen Gatesy,et al.  Standing the test of time , 2003, Nature.

[17]  M. Meisner,et al.  Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications , 2002, Intensive Care Medicine.

[18]  C. Subbe,et al.  Validation of a modified Early Warning Score in medical admissions. , 2001, QJM : monthly journal of the Association of Physicians.

[19]  G. Ricevuti,et al.  Plasma Levels of Procalcitonin and Interleukin-6 in Acute Myocardial Infarction , 2001, Inflammation.

[20]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[21]  D M Linton,et al.  Severity of disease classification system. , 1991, Critical care medicine.

[22]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[23]  J. Parrillo,et al.  Cardiogenic Shock , 1971, Journal of the American Heart Association.

[24]  M. Al-Haddad,et al.  Recognizing the critically ill patient , 2013 .

[25]  J. Vincent,et al.  Circulatory shock. , 2013, The New England journal of medicine.

[26]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.